Ad is loading...
MNBAX
Price
$20.02
Change
-$0.22 (-1.09%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

MNBAX vs RLEFX

Header iconMNBAX vs RLEFX Comparison
Open Charts MNBAX vs RLEFXBanner chart's image
Manning & Napier Pro-Blend Extnd Term S
Price$20.02
Change-$0.22 (-1.09%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
MNBAX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MNBAX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNBAX is a Buy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. MNBAX (552M). RLEFX pays higher dividends than MNBAX: RLEFX (2.42) vs MNBAX (1.77). MNBAX was incepted earlier than RLEFX: MNBAX (31 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. MNBAX (56.00). RLEFX has a lower initial minimum investment than MNBAX: RLEFX (250) vs MNBAX (2000). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. MNBAX (14.21). RLEFX return over 5 years is better than : 35.95 vs. MNBAX (14.97).
MNBAXRLEFXMNBAX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years9 years-
Gain YTD7.40314.21152%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets552M236B0%
Annual Yield % from dividends1.772.4273%
Returns for 1 year14.2121.0967%
Returns for 3 years-5.9710.95-55%
Returns for 5 years14.9735.9542%
Returns for 10 years16.69N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology